International Journal of Drug Policy
Volume 21, Issue 2 , Pages 112-114, March 2010

Young people and drugs: Next generation of harm reduction

  • Simona Merkinaite

      Affiliations

    • Eurasian Harm Reduction Network, Siauliu 5/1-21, Vilnius 01133, Lithuania
    • Corresponding Author InformationCorresponding author. Tel.: +370 5 2609007/91600 fax: +370 5 2691601.
  • ,
  • Jean Paul Grund

      Affiliations

    • Addiction Research Center, Utrecht, The Netherlands
    • Hague Department of Public Health, The Netherlands
  • ,
  • Allen Frimpong

      Affiliations

    • Youth Rise, United States

Received 18 September 2009; received in revised form 24 November 2009; accepted 24 November 2009. published online 28 December 2009.

Abstract 

Globally, young people under 25 accounted for an estimated 45% of all new HIV infections in 2007. Across the Eastern Europe and Central Asia region as many as 25% of injecting drug users (IDUs) are younger than 20. The Eurasian Harm Reduction assessment of young peoples’ (under 25) drug use, risk behaviours and service availability and accessibility confirms, young people at risk of injecting, or those already experimenting with injecting drugs, find themselves isolated from health and prevention services, which increases the risks for health and social harms, while the approach towards young peoples’ use rely heavily on law enforcement. Denying young drug users’ access to life-saving drug treatment and other harm reduction services contributes to the risk environment surrounding their use and violates their right to health and well-being as identified in the Convention on the Rights of the Child. Governments, health care providers and harm reduction services should work together to create an environment in which young people can access needed services, including non-judgmental and low-threshold approaches offered by harm reduction programs.

Keywords: Young people, Harm reduction, Drug injecting

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(09)00158-3

doi:10.1016/j.drugpo.2009.11.006

International Journal of Drug Policy
Volume 21, Issue 2 , Pages 112-114, March 2010